Hans Krantz

Hans Krantz, listed as board member, appears in our data through filings on Generic Sweden AB (publ) shares, published by Finansinspektionen. We count 12 filings; the first trade dates from 1 July 2019 and the latest from 1 September 2025.

The open-market side counts 4 purchases for €993k alongside 8 sales for €9.7M. Sales outweigh purchases by €8.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at no purchases and 3 sales.

The median purchase comes to €203k. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

On 1 September 2025 came the latest disclosure, an open-market sale for €1.8M in Generic Sweden AB (publ). The last purchase on record was published on 18 December 2020, which is 2,150 days ago. Filings reach the Finansinspektionen feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.